
zzso Y, zzso zzso and pancreatic zzso share an evolutionary zzso zzso zzso zzso a structure generally known to be zzso to the attack of common zzso but a potential target for specialized zzso zzso zzso human zzso zzso IV (also termed CD 26) liberated zzso zzso from both, zzso Y and zzso zzso with very high specific activities and zzso values in the zzso range, but almost no zzso from pancreatic zzso Other zzso zzso exhibited low zzso zzso liberation of zzso zzso or totally no activity zzso zzso zzso as was also observed with zzso zzso zzso M, zzso zzso When human serum was incubated with zzso Y or zzso zzso at zzso and zzso zzso zzso was detected as a zzso of both zzso zzso of zzso in serum was blocked in the presence of zzso and zzso A zzso specific, competitive zzso of zzso zzso zzso zzso of zzso Y or zzso zzso with zzso zzso cultivated zzso cells from human zzso zzso also yielded zzso zzso zzso IV could be zzso on most zzso cells by a specific zzso We suggest that zzso zzso IV might be involved in the degradation of zzso Y and zzso zzso to zzso truncated zzso zzso and zzso zzso Since specific binding to zzso but not to zzso zzso of zzso zzso zzso receptors requires intact zzso as well as zzso of zzso Y and zzso zzso removal of their zzso zzso by zzso zzso IV zzso them for binding to one zzso zzso 

